Global Neuropathic Pain Market

Global Neuropathic Pain Market, Forecast to 2030

Report ID: PNPH1181 Industry: Pharma & Biotech Category: Market Analysis Reports
Request Free Sample

  1. Introduction

  1. Definition of Neuropathic Pain Market

  1. Scope of the Report

  1. Methodology

  1. Executive Summary

  1. Market Overview

  1. Market Definition and Segmentation

  1. Market Dynamics

  1. Drivers

  1. Restraints

  1. Opportunities

  1. Porter's Five Forces Analysis

  1. PESTEL Analysis

  1. Neuropathic Pain Market, By type:

  1. Spinal cord stimulation (SCS) devices

  1. External peripheral nerve stimulation

  1. Transcutaneous electrical nerve stimulation (TENS) devices

  1. Neuropathic Pain Market, By product type:

  1. Rechargeable

  1. Non-rechargeable

  1. Neuropathic Pain Market, By procedure:

  1. Invasive

  1. Non-invasive

  1. Neuropathic Pain Market, By technology:

  1. Transcutaneous electrical nerve stimulation

  1. Transcranial magnetic stimulation

  1. Respiratory electrical stimulation

  1. Neuropathic Pain Market, By modality:

  1. Stationary

  1. Portable

  1. Neuropathic Pain Market, By mode of purchase:

  1. Over-the-counter devices

  1. Prescription-based devices

  1. Neuropathic Pain Market, By pain type:

  1. Peripheral neuropathy

  1. Entrapment neuropathy

  1. Phantom limb neuropathy

  1. Trigeminal neuralgia

  1. Post herpetic neuralgia (PHN)

  1. Post traumatic neuropathy

  1. Foot pain

  1. Coccydynia

  1. Neuropathic Pain Market, By indication:

  1. Spinal stenosis

  1. Chemotherapy-induced peripheral neuropathy

  1. Diabetic neuropathy

  1. Others

  1. Neuropathic Pain Market, By end-user:

  1. Hospitals

  1. Clinics

  1. Home healthcare

  1. Ambulatory surgical centers

  1. Others

  1. Neuropathic Pain Market, By distribution channel:

  1. Direct tender

  1. Third party distributor

  1. Others

  1. Neuropathic Pain Market, By Geography

  1. North America

  1. United States

  1. Canada

  1. Europe

  1. United Kingdom

  1. Germany

  1. France

  1. Spain

  1. Italy

  1. Rest of Europe

  1. Asia-Pacific

  1. China

  1. Japan

  1. India

  1. South Korea

  1. Australia

  1. Rest of Asia-Pacific

  1. Latin America

  1. Brazil

  1. Mexico

  1. Rest of Latin America

  1. Middle East & Africa

  1. Saudi Arabia

  1. United Arab Emirates

  1. South Africa

  1. Rest of Middle East & Africa

  1. Competitive Landscape

  1. Company Profiles

  1. Medtronic

  1. Company Overview

  1. Product Portfolio and Description

  1. Key Highlights

  1. Financial Overview

  1. Boston Scientific Corporation

  1. Abbott

  1. Nervo Corp.

  1. Omron Healthcare, Inc.

  1. Interger Holdings Corporation

  1. Avns

  1. B.Braun Melsungen Ag

  1. Cirtec

  1. Electrocore, Inc.

  1. Neurometrix, Inc.

  1. Polar Medical

  1. Spr Therapeutics

  1. Stimwave Llc.

  1. Sunmed

  1. Conclusion and Future Outlook

  1. Appendix

  1. Research Methodology

  1. About the Pharmanucleus

  1. Disclaimer



$3000

Most Popular

$5000

$3450

Most Popular

$5450

Have a Question?

Do you have any query on this report. Click below to clear all your queries.

Request Customization

Why Choose Us

Inclusion of Pre-clinical Molecules

Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!

Start-up
Profiling

One of our marquee services We profile relevant start-up companies in the market.

KOL
Insight's

Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.

Specialized in Healthcare

Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.